You have 9 free searches left this month | for more free features.

pertuzumab

Showing 26 - 50 of 142

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Los Angeles, California
  • +4 more
Jul 19, 2022

Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)

Not yet recruiting
  • Breast Neoplasms
  • Guangzhou, Gangdong, China
    Sun-yat sen university cancer center
Jul 30, 2023

HER-2 Positive Breast Cancer, Breast Cancer, Stage II Breast Cancer Trial in Boston, Nashville (T-DM1, Pertuzumab, Excision of

Active, not recruiting
  • HER-2 Positive Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +3 more
Mar 4, 2022

Breast Cancer Trial in Boston, Milford, South Weymouth (Paclitaxel, Trastuzumab, Pertuzumab)

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +4 more
Feb 4, 2022

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena

Active, not recruiting
  • HER2-positive Breast Cancer
  • +9 more
  • pertuzumab
  • +3 more
  • Duarte, California
  • +2 more
Mar 17, 2022

Breast Cancer Trial in Chicago, Ann Arbor, New Haven (Trastuzumab, Pertuzumab, Tocilizumab)

Completed
  • Breast Cancer
  • Chicago, Illinois
  • +2 more
Sep 8, 2021

Breast Cancer, Neoadjuvant Therapy Trial in Beijing (Utidelone, Carboplatin, Epirubicin)

Not yet recruiting
  • Breast Cancer
  • Neoadjuvant Therapy
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Aug 1, 2023

Breast Cancer Trial in Houston, Sugar Land (T-DM1, Trastuzumab, Lapatinib)

Completed
  • Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Metastatic Breast Cancer With a Isolated Brain Progression Trial in France (Tucatinib, Pertuzumab, Trastuzumab)

Recruiting
  • Metastatic Breast Cancer With a Isolated Brain Progression
  • Angers, France
  • +33 more
Aug 10, 2022

Solid Tumor, Haematological Malignancy, Colorectal Tumors Trial in United Kingdom (Trastuzumab, Pertuzumab)

Recruiting
  • Solid Tumor
  • +10 more
  • Belfast, United Kingdom
  • +25 more
Mar 28, 2023

Breast Cancer Trial in Villejuif (Atezolizumab Injection, Ipatasertib, Bevacizumab)

Recruiting
  • Breast Cancer
  • Atezolizumab Injection
  • +4 more
  • Villejuif, France
    Gustave Roussy
Mar 9, 2022

Breast Cancer Trial in China (Docetaxel, Pertuzumab, Placebo)

Completed
  • Breast Cancer
  • Beijing, China
  • +14 more
Nov 15, 2021

Locally Advanced Breast Cancer Trial in New York (Docetaxel, Carboplatin, Trastuzumab)

Terminated
  • Locally Advanced Breast Cancer
  • New York, New York
  • +2 more
Oct 18, 2021

Breast Tumors, HER2-positive Breast Cancer, Circulating Tumor Cell Trial in São Paulo (Pertuzumab, Trastuzumab, Circulating

Recruiting
  • Breast Neoplasms
  • +2 more
  • Pertuzumab
  • +2 more
  • São Paulo, Brazil
    A.C. Camargo Cancer Center
Jul 28, 2021

Breast Cancer, Heart Failure Trial in Canada, Russian Federation (Trastuzumab, Pertuzumab, Trastuzumab emtansine)

Recruiting
  • Breast Cancer
  • Heart Failure
  • Hamitlon, Ontario, Canada
  • +3 more
Jun 21, 2022

Breast Cancer Trial in Sweden (Trastuzumab deruxtecan, Docetaxel, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +9 more
  • Malmö, Sweden
  • +6 more
Jun 8, 2023

Breast Carcinoma Trial in Orange (Carboplatin, Paclitaxel, Bevacizumab)

Recruiting
  • Breast Carcinoma
  • Orange, California
    UC Irvine Health/Chao Family Comprehensive Cancer Center
Apr 15, 2021

Metastatic Breast Cancer Trial in United States (Pertuzumab, Trastuzumab)

Completed
  • Metastatic Breast Cancer
  • Tucson, Arizona
  • +15 more
Dec 3, 2021

Metastatic or Locally Advanced Malignancies Trial in Germany (Vemurafenib, Cobimetinib, Atezolizumab)

Recruiting
  • Metastatic or Locally Advanced Malignancies
  • Berlin, Germany
  • +5 more
Jan 2, 2023

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

HER2-positive Breast Cancer, Brain Metastases Trial in Beijing, Guangzhou, Hangzhou (Trastuzumab, Taxanes, Pertuzumab)

Not yet recruiting
  • HER2-positive Breast Cancer
  • Brain Metastases
  • Beijing, Beijing, China
  • +2 more
May 28, 2021

Breast Tumors, Breast Diseases Trial in New York (Anastrozole, Palbociclib, Trastuzumab)

Recruiting
  • Breast Neoplasms
  • Breast Diseases
  • New York, New York
  • +4 more
Jun 25, 2021

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022

Breast Cancer Trial in Tampa (Gemcitabine, Trastuzumab, Pertuzumab)

Completed
  • Breast Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Feb 2, 2021